Dr Agarwal's Hea

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE943P01029
  • NSEID: AGARWALEYE
  • BSEID: 544350
INR
511.75
8.5 (1.69%)
BSENSE

Dec 05

BSE+NSE Vol: 87.12 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Net Sales
1,711.00
1,332.15
1,017.98
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,711.00
1,332.15
1,017.98
Raw Material Cost
1.18
1.08
1.76
Purchase of Finished goods
173.73
140.83
114.76
(Increase) / Decrease In Stocks
-12.81
-5.07
-3.06
Employee Cost
326.87
242.83
190.40
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
473.27
368.00
267.57
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
292.38
222.22
176.20
Total Expenditure (Excl Depreciation)
1,254.62
969.89
747.63
Operating Profit (PBDIT) excl Other Income
456.38
362.26
270.35
Other Income
46.02
44.30
13.51
Operating Profit (PBDIT)
502.40
406.56
283.86
Interest
108.79
95.62
71.97
Exceptional Items
-3.02
0.00
0.00
Gross Profit (PBDT)
390.59
310.94
211.89
Depreciation
230.74
170.37
128.30
Profit Before Tax
159.85
140.57
83.59
Tax
49.51
45.52
-19.64
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
110.34
95.05
103.23
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
110.34
95.05
103.23
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-26.88
-11.99
-9.13
Other related items
0.00
0.00
0.00
Consolidated Net Profit
83.46
83.06
94.10
Equity Capital
31.59
9.33
7.93
Face Value
10.0
10.0
10.0
Reserves
1,835.00
1,330.08
0.00
Earnings per share (EPS)
26.42
89.02
118.66
Diluted Earnings per share
2.78
3.13
130.18
Operating Profit Margin (Excl OI)
26.67%
27.19%
26.56%
Gross Profit Margin
22.83%
23.34%
20.81%
PAT Margin
6.45%
7.14%
10.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 28.44% vs 30.86% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 0.48% vs -11.73% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.98% vs 34.00% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 13.77% vs 32.86% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Dr Agarwal's Hea With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,711.00
3,035.00
-1,324.00
-43.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,711.00
3,035.00
-1,324.00
-43.62%
Raw Material Cost
1.18
0.00
1.18
Purchase of Finished goods
173.73
640.40
-466.67
-72.87%
(Increase) / Decrease In Stocks
-12.81
-13.40
0.59
4.40%
Employee Cost
326.87
499.40
-172.53
-34.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
473.27
0.00
473.27
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
292.38
1,125.90
-833.52
-74.03%
Total Expenditure (Excl Depreciation)
1,254.62
2,252.30
-997.68
-44.30%
Operating Profit (PBDIT) excl Other Income
456.38
782.70
-326.32
-41.69%
Other Income
46.02
31.90
14.12
44.26%
Operating Profit (PBDIT)
502.40
814.60
-312.20
-38.33%
Interest
108.79
90.20
18.59
20.61%
Exceptional Items
-3.02
10.80
-13.82
-127.96%
Gross Profit (PBDT)
390.59
735.20
-344.61
-46.87%
Depreciation
230.74
177.30
53.44
30.14%
Profit Before Tax
159.85
557.90
-398.05
-71.35%
Tax
49.51
143.40
-93.89
-65.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
110.34
414.50
-304.16
-73.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
110.34
414.50
-304.16
-73.38%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-26.88
-30.00
3.12
10.40%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
83.46
384.50
-301.04
-78.29%
Equity Capital
31.59
80.00
-48.41
-60.51%
Face Value
10.00
2.00
0.00
Reserves
1,835.00
2,057.80
-222.80
-10.83%
Earnings per share (EPS)
26.42
9.61
16.81
174.92%
Diluted Earnings per share
2.78
9.61
-6.83
-71.07%
Operating Profit Margin (Excl OI)
26.67%
25.79%
0.00
0.88%
Gross Profit Margin
22.83%
24.22%
0.00
-1.39%
PAT Margin
6.45%
13.66%
0.00
-7.21%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,711.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 28.44% vs 30.86% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 83.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.48% vs -11.73% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.98% vs 34.00% in Mar 2024

Annual - Interest
Interest 108.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.77% vs 32.86% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.67%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024